Business Description
GlucoTrack Inc
NAICS : 339112
SIC : 3841
ISIN : US45824Q8042
Total Employee Number:
15Description
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.1 | |||||
Equity-to-Asset | -0.2 | |||||
Debt-to-Equity | -4.22 | |||||
Debt-to-EBITDA | -0.21 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 74 | |||||
3-Year EPS without NRI Growth Rate | 75.4 | |||||
3-Year FCF Growth Rate | 72.9 | |||||
3-Year Book Growth Rate | -80.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 75.87 | |||||
9-Day RSI | 56.78 | |||||
14-Day RSI | 46.44 | |||||
3-1 Month Momentum % | -39.66 | |||||
6-1 Month Momentum % | -89.32 | |||||
12-1 Month Momentum % | -93.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.85 | |||||
Quick Ratio | 0.85 | |||||
Cash Ratio | 0.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -572.1 | |||||
Shareholder Yield % | -386.42 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -447.6 | |||||
ROA % | -209.51 | |||||
ROIC % | -683.5 | |||||
3-Year ROIIC % | -361.26 | |||||
ROC (Joel Greenblatt) % | -10807.59 | |||||
ROCE % | -415.18 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.13 | |||||
EV-to-EBITDA | -0.13 | |||||
EV-to-FCF | -0.13 | |||||
Earnings Yield (Greenblatt) % | -769.23 | |||||
FCF Yield % | -654.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GCTK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GlucoTrack Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -18.04 | ||
| Beta | 2.5487 | ||
| 3-Year Sharpe Ratio | -0.88 | ||
| 3-Year Sortino Ratio | -1.12 | ||
| Volatility % | 122.24 | ||
| 14-Day RSI | 46.44 | ||
| 14-Day ATR ($) | 0.058751 | ||
| 20-Day SMA ($) | 0.36107 | ||
| 12-1 Month Momentum % | -93.15 | ||
| 52-Week Range ($) | 0.2907 - 14.14 | ||
| Shares Outstanding (Mil) | 6.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GlucoTrack Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GlucoTrack Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 123 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 32 days | ||
| General meeting for 2025 | 2026-07-15 | In 2 days | ||
| First quarter earnings results for 2026 | 2026-05-14 | 0.70 (-2.78%) | ||
| Annual report for 2025 | 2026-03-30 | 0.99 (-28.25%) | ||
| Fourth quarter earnings results for 2026 | 2026-03-30 | 0.99 (-28.25%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 5.93 (+4.50%) | ||
| Q3 Virtual Investor Summit | 2025-09-16 13:30 | 7.78 (-10.47%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 5.80 (+0.87%) | ||
| 0.0166667:1 Stock Split | 2025-06-16 | 5.69 (-10.39%) |
Show
Entries
GlucoTrack Inc Frequently Asked Questions
What is GlucoTrack Inc(GCTK)'s stock price today?
The current price of GCTK is $0.40. The 52 week high of GCTK is $14.14 and 52 week low is $0.29.
When is next earnings date of GlucoTrack Inc(GCTK)?
The next earnings date of GlucoTrack Inc(GCTK) is 2026-08-14 Est..
Does GlucoTrack Inc(GCTK) pay dividends? If so, how much?
GlucoTrack Inc(GCTK) does not pay dividend.
Guru Commentaries on NAS:GCTK
No articles.
Press Release
Articles on GlucoTrack Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers